| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/05/2008 | US20080131501 enhanced immediate release formulations of topiramate, in which 80% of the active ingredient is released in the period of time of not more than 30 min. These formulations may be advantageously used for the treatment of acute neurological conditions, such as migraine. |
| 06/05/2008 | US20080131484 Intraocular drug delivery systems |
| 06/05/2008 | US20080131482 Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix |
| 06/05/2008 | US20080131481 Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| 06/05/2008 | US20080131430 Therapeutic Administration Of The Scrambled Anti-Angiogenic Peptide C16Y |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131397 Uisng Apolipoprotein H (Apo-H) as modulating agent in prevention and treatment of cell proliferative, eye, reproductive, gastrointestinal and joint disorders |
| 06/05/2008 | US20080131372 Extruding mixture of alpha-2 adrenergic receptor agonist (brimonidine) and biodegradable polylactide |
| 06/05/2008 | US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease |
| 06/05/2008 | DE102006056558A1 Intraocular fluid, useful in eye surgery, e.g. during lens replacement for cataract treatment, contains blue light absorbing colorant to prevent damage to retina |
| 06/05/2008 | CA2668814A1 Water insoluble polymer matrix for drug delivery |
| 06/04/2008 | EP1927353A1 Remedy for corneal diseases |
| 06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
| 06/04/2008 | EP1927348A1 Anticonvulsive pharmaceutical compositions |
| 06/04/2008 | EP1926483A2 Treatment of autoimmune diseases |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | EP1377316B1 Pharmaceutical composition based on azalides for topical application in ophthalmology |
| 06/04/2008 | EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 06/04/2008 | CN101193634A Roflumilast eye drop |
| 06/04/2008 | CN100391538C Ectocornea extension promoters |
| 06/04/2008 | CN100391503C Use of Chinese and Western medicine composition in preparing medicine for preventing and treating xeroma |
| 06/04/2008 | CN100391475C Eye food peptide injection and its use in preparing medincine for treating hypometropia |
| 06/04/2008 | CN100391461C Hypotensive lipid and timolol compositions and methods of using same |
| 06/04/2008 | CN100391449C Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 06/04/2008 | CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base |
| 06/03/2008 | US7381704 Methods for use of short bioactive peptides |
| 06/03/2008 | US7381404 Treatment for dry macular degeneration |
| 06/03/2008 | CA2536069C Use of green porphyrins in ocular diagnosis and therapy |
| 06/03/2008 | CA2368186C Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 05/29/2008 | WO2008064039A2 Prostaglandin prodrugs as ocular hypotensive agents |
| 05/29/2008 | WO2008063639A2 Compositions and methods for preserving cells of the eye |
| 05/29/2008 | WO2008062463A2 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-l,2-thiazine-6-sulfonamide-l,l-dioxide |
| 05/29/2008 | WO2008062040A1 Anticonvulsive pharmaceutical compositions |
| 05/29/2008 | WO2008061536A1 Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2007005300A3 Treatment of dry eye |
| 05/29/2008 | US20080125454 Methods and Compositions for Treatment of Scleritis and Related Disorders |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125406 Method for Treating Primary and Secondary Forms of Glaucoma |
| 05/29/2008 | US20080125405 Composition for treating or preventing olfactory disorder |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124376 Ocular devices and methods of making and using thereof |
| 05/29/2008 | CA2689293A1 Prostaglandin prodrugs |
| 05/29/2008 | CA2670439A1 Anticonvulsive pharmaceutical compositions |
| 05/29/2008 | CA2670409A1 Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye |
| 05/29/2008 | CA2669124A1 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 05/29/2008 | CA2666405A1 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide |
| 05/28/2008 | EP1925306A2 Agents which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (CTGF) to Lower Intraocular Pressure |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1344526B1 Preventives/remedies for inflammatory airway diseases |
| 05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
| 05/28/2008 | CN101185723A Traditional Chinese medicine preparation for treating diabetic retina affection |
| 05/28/2008 | CN101185710A Powder agent medicine for treating chronic otitis media suppurative |
| 05/28/2008 | CN101185708A Powder agent medicine for treating acute otitis media suppurative |
| 05/28/2008 | CN101185700A Medicine for treating cataract |
| 05/28/2008 | CN101185687A Fumigation and cleaning medicine for treating acute conjunctivitis |
| 05/28/2008 | CN101185685A Fumigation and cleaning medicine for treating epidemic acute conjunctivitis |
| 05/28/2008 | CN101185662A Method and use for preparing novel medicine for treating diabetes prepared from tuber fern |
| 05/28/2008 | CN101185650A Penciclovir ophthalmic temperature sensitivity in situ gel preparation and preparation method thereof |
| 05/28/2008 | CN101185645A Cromoglyn sodium gel eyedrop and preparation method |
| 05/28/2008 | CN100390173C Tricyclic compound |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/28/2008 | CN100389820C Therapeutic agent comprising botulinum neurotoxin |
| 05/28/2008 | CN100389819C Chinese-medicine for treating cataracta ophthalmopathy |
| 05/28/2008 | CN100389782C Eyesight-improving capsule and preparation process thereof |
| 05/28/2008 | CN100389770C Transparent eye drops containing latanoprost |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378444 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378425 For preventing, treating and/or improving a disease against which a sigma receptor binding action and/or an acetylcholinesterase inhibitory action is efficacious |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378080 Detection, measurement, calibration gene expression |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/27/2008 | CA2264895C Device and method for treating ophthalmic diseases |
| 05/22/2008 | WO2008060572A1 Use of gabapentin and pregabalin prodrugs for treating tinnitus |
| 05/22/2008 | WO2008060377A2 Placental or umbilical cord tissue compositions |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059502A2 Contact lens compositions |
| 05/22/2008 | WO2008059501A2 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| 05/22/2008 | WO2008059224A1 Use of buprenorphine or n-alkylated derivatives thereof for wound healing |
| 05/22/2008 | WO2008024734A3 Use of pkc inhibitors in particular indolylmaleimide derivatives in ocular diseases |
| 05/22/2008 | WO2007130960A3 Stable ophthalmic oil-in-water emulsions with omega-3 fatty acids for alleviating dry eye |
| 05/22/2008 | US20080119560 Use treating glaucoma, ocular hypertension, or baldness; prostaglandin EP2 selective agonists are 1-hydroxy-3-chloro-4-carboxylalk(en)yl-5-(aryloxyalkyl)cyclopentanes |
| 05/22/2008 | US20080119546 Treatment of hyperproliferative conditions of body surfaces |
| 05/22/2008 | US20080119539 Therapeutic amides |
| 05/22/2008 | US20080119538 Therapeutic compounds |
| 05/22/2008 | US20080119534 Benzimidazole Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119462 Method for treating vascular hyperpermeable disease |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080118549 Sustained release intraocular implants and methods for treating ocular vasculopathies |
| 05/22/2008 | US20080118548 Associated with diabetes; implanting an alpha-2 adrenergic receptor agonist, such as brimonidine, associated with a biodegradable polymer matrix; hypotensive agents, antiischemic agents; glaucoma |
| 05/22/2008 | US20080118500 Nanosphere contains phospholipid/cholesterol particle comprising vesicle, and agent-carrying component capable of forming complex with therapeutic agent via electrostatic charge-charge interaction or hydrophobic-hydrophobic interaction; cyclodextrins |